XML 27 R17.htm IDEA: XBRL DOCUMENT

Marketable EQUITY Securities

9 Months Ended

Sep. 30, 2024

9. Marketable EQUITY Securities

Marketable equity securities with readily determinable market prices consisted of the following as of September 30, 2024 and December 31, 2023:

Schedule of marketable securities
	Marketable equity securities at September 30, 2024
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	5,476,000	$	672,000	$	(5,461,000	)	$	687,000

	Marketable equity securities at December 31, 2023
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	5,119,000	$	12,000	$	(5,104,000	)	$	27,000

The Company’s investment in marketable equity securities is revalued on each balance sheet date.